Skip to main content
Equibles

Parallel Advisors, LLC

Position in MESO — Mesoblast Ltd

CIK 1690010 SAN FRANCISCO, CA
Back to MESO Full portfolio

Position in MESO

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$14,625
-$4,676 QoQ
Shares Held
1,081
-13.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 72 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in MESO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $359,928,308 across 168 Biotechnology names. MESO ranks #69 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CORT
Corcept Therapeutics Inc
 3,962,177 $344,511,290
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 5,389 $2,676,877
3 RCUS
Arcus Biosciences, Inc.
 86,557 $2,668,552
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,063 $662,823
5 KRYS
Krystal Biotech, Inc.
 1,699 $631,467
6 ARGX
Argenx SE
 640 $593,772
7 INCY
Incyte Corp
 4,961 $562,378
8 VKTX
Viking Therapeutics, Inc.
 13,833 $539,625

All Filings in MESO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,625 1,081
2026-03-31 $19,301 1,255
2025-12-31 $21,485 1,191
2025-09-30 $17,930 1,113
2025-06-30 $10,160 933
2025-03-31 $9,459 758
2024-12-31 $15,364 776
2024-09-30 $2,042 250
2024-06-30 $5,148 756
2023-06-30 $742 190
2023-03-31 $625 190
2022-03-31 $704 167
2021-12-31 $3,585 747
2021-09-30 $4,231 704
2021-06-30 $5,265 704
2021-03-31 $5,822 704
2020-12-31 $5,976 704
2020-09-30 $13,087 704
2020-06-30 $9,009 791